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Neuronal activityThe ubiquitin proteasome system is one of the principlemechanisms for the regulation of protein homeostasis in
mammalian cells. In dynamic cellular structures such as neuronal synapses, ubiquitin proteasome system and
protein translation provide an efﬁcient way for cells to respond promptly to local stimulation and regulate
neuroplasticity. The majority of research related to long-term plasticity has been focused on the postsynapses
and has shown that ubiquitination and subsequent degradation of speciﬁc proteins are involved in various
activity-dependent plasticity events. This review summarizes recent achievements in understanding
ubiquitination of postsynaptic proteins and its impact on synapse plasticity and discusses the direction for
advancing future research in the ﬁeld.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Synapses and synapse plasticity play critical roles in determining
the connectivity and strength of the neural circuit. Multiple layers of
regulation provide efﬁcient management of synaptic transmission
during neural development and in response to stimulation (activity).
The regulation that takes place locally, at or near the synapses, has
received tremendous attention in the past decade. This is mainly
because regulation at the local level provides not only a quicker
response to stimulation but also the speciﬁcity and selectivity for regu-
lation of different neurons, axons, dendrites, and even synapses [1–5].
Local regulation can be divided into two categories based on whether
it affects protein content. 1) Regulation that does not affect protein con-
tent can occur through signaling cascades to mediate protein–protein
interaction, protein trafﬁcking, and posttranslational modiﬁcations
(except for ubiquitination). 2) Regulation that affects total or speciﬁc
protein content can occur through local protein translation or turnover.
Of these, local protein turnover has not been well studied but is emerg-
ing as an important ﬁeld. This is particularly true for proteasome-
mediated degradation, as the ubiquitin proteasome system (UPS)
provides spatial and target-speciﬁc degradation, which are ideal for
dynamic and heterogeneous compartments such as synapses. Although
UPS is strongly associated with many pathophysiological conditions inchool of Molecular and Cellular
South Goodwin Ave., Urbana, IL
3.the central nervous system such as ischemia or hypoxia [6,7], and
neurodegenerative diseases [8–10], this review will primarily focus on
ubiquitination-mediated degradation of synaptic or synapse-related
proteins in physiological conditions. Due to the increased number
of recent studies showing activity-dependent regulation of UPS at
postsynapses, the focus of this review will be on the events that occur
in postsynapses.
2. Proteasome and protein ubiquitination
In eukaryotic cells proteasomes are protein complexes whose
function is to degrade misfolded proteins and certain other proteins
destined to be eliminated [11]. A small regulatory protein known as
ubiquitin is covalently linked to proteins that are to be degraded
by the proteasome. This tagging reaction, which is called protein
ubiquitination, is triggered by a series of enzymatic reactions (Fig. 1).
Initially, E1 ubiquitin-activating enzyme binds to a ubiquitin molecule
and then catalyzes a reaction to link ubiquitin onto E1 through a
thioester linkage. Secondly, E2 ubiquitin-conjugating enzyme transfers
the ubiquitin from E1 to an active site on E2 through a transes-
teriﬁcation reaction. Finally, E3 ligase, which interacts with both the
substrate and E2, catalyzes the transfer of ubiquitin from E2 to the
substrate [11]. Currently several hundred E3 ligases have been identi-
ﬁed; substantially these provide the speciﬁcity of ubiquitination for
particular proteins.
Many studies have elucidated the importance of proteasomes in reg-
ulating functional and structural synapse plasticity [3,12–18]. It is not
surprising that efforts to better understand the role of proteasomes
Fig. 1. The general ubiquitination pathway. The pathway starts with an ATP-dependent
activation of Ubiquitin (Ub) by an E1 ubiquitin-activating enzyme (E1). An E2
conjugating-enzyme (E2) then catalyzes the transfer of a ubiquitin from an E1 to an E2.
When a substrate is brought by an E3 ligase (E3) to a Ub-conjugated E2, the Ub is
transferred to the substrate on speciﬁc lysine residues. Depending on the functional
domain in E3 ligases, this step can be a direct Ub transfer from E2 to the substrate or a
two-step process involving a transient binding of E3s to the Ub. As this same
ubiquitination pathway repeats, a protein substrate can be poly-ubiquitinated.
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involved in synapse plasticity, since this is the rate-limiting step during
protein ubiquitination as well as the step where speciﬁcity comes into
play. Several studies have linked different E3 ligases to the regulation
of synapse plasticity and the associated animal behavior [19–21].
Studies have also uncovered ubiquitinated proteins in postsynapses by
both candidate-based [22] and unbiased proteomic approaches [23]
(Table 1). However, because of the number of E3 ligases and all their
possible substrates, linking the critical E3 ligase and its substrate to
synapse plasticity is still considered an understudied subject.
3. Ubiquitination of postsynaptic scaffold proteins
The postsynaptic density (PSD) is a complex of proteins localized in
the postsynaptic membrane that provides functional and structural
support for excitatory synaptic transmission [24]. The size, integrity,
and content of PSD are known to affect the strength of the synaptic
transmission [24]. The cytoskeleton protein is one of the major groups
of components identiﬁed in the PSD [25]. Among those identiﬁed,
the ﬁlament actin (F-actin) plays the most critical role in mediating
dendritic spine morphology and function [26,27]. Although it is unclear
whether F-actin can be ubiquitinated, F-actin polymerization can beTable 1
The summary of ubiquitinated proteins in the postsynapses described in this article.
Postsynaptic protein
category









Receptor protein/subunit AMPAR (GluA1 subunit) Nedd4-1 [52]
AMPAR (GluA2 subunit) [53]




Signaling molecule Arc Ube3a, Triad3a [67–70]
CaMKII [23]
SPAR β-TRCP [76]regulated indirectly by ubiquitination through the Wiskott-Aldrich
syndrome protein (WASP) family member WASH-dependent mecha-
nism [28]. Therefore, it would be an important topic to understand
whether F-actin level and polymerization at synapses can also be
regulated by ubiquitination-related mechanisms as that would likely
in turn affect synapse plasticity.
Besides cytoskeleton proteins, scaffold proteins are another group
of structural components in PSD that have the ability to affect the
structure and complexity of PSD depending on their protein interaction
network. Among several PSD-associated scaffold proteins regulated
by UPS, PSD-95 is of particular interest because it is the best studied
member of the membrane-associated guanylate kinase (MAGUK)
family of PDZ domain-containing proteins [29]. The ﬁrst study
that identiﬁed PSD-95 as being poly-ubiquitinated linked it to
NMDA-induced AMPA-receptor endocytosis [30]. This report also
identiﬁed the ubiquitin E3 ligase speciﬁc for PSD-95 as murine double
minute-2 (Mdm2), the well-known E3 ligase widely studied for its
role in ubiquitinating the tumor suppressor p53 and regulating tumor-
igenesis [31]. Additionally this study reported a potential PEST sequence
(a peptide sequence linked to protein degradation that is rich in
proline, glutamic acid, serine, and threonine) [32] in Mdm2-mediated
ubiquitination; however, the function of this sequence in neuronal
cells is currently unconﬁrmed. This is primarily because the PEST-
deletion mutant of PSD-95 showed an abnormal dendritic distribution
[33] and could not be used for studying the physical contact between
PSD-95 and Mdm2 under physiological conditions. Despite this, the
fact of PSD-95 ubiquitination is not in doubt as many follow-up studies
have conﬁrmed this observation and suggested several regulatory
mechanisms underlying Mdm2-mediated PSD-95 ubiquitination.
These include the action of cyclin-dependent kinase 5 (Cdk5) [34],
the level of lipoprotein receptor LRP1 [35], and the activation of
activity-dependent transcription factor myocyte enhancer factor 2
(MEF2) [36]. The latter study also connected Mdm2-mediated PSD-95
ubiquitination to the deﬁciency in activity-dependent synapse elimina-
tion observed in themousemodel of fragile X syndrome (FXS), themost
common genetic form of mental retardation and autism [37,38].
Another important scaffold protein known to be ubiquitinated is
Homer1a. Homers are a family of scaffold proteins with 3 major
isoforms (Homer1, Homer2, and Homer3), which are thought to medi-
ate synapse signaling and are involved in learning and memory [39].
Although Homers are known to be associated with UPS [40], thus
far, Homer1a is the only isoform that has been conﬁrmed as being
ubiquitinated [40–42]. Homer1a, a short splice variant of Homer1,
lacks a coiled-coil domain for oligomerization [43] and has been
suggested to be a competitor of full-length Homers inmultiple signaling
pathways [43,44]. The ubiquitination of Homer1a occurs at an 11-amino
acid region in its C-terminal end [42] and is thought to play a role in
synapse plasticity [45]. The ubiquitination of other Homers has not yet
been conﬁrmed; however, given the number of Homers known to be
associated with synapse plasticity and related behavioral tests [46,47],
it is highly possible that UPS-mediated turnover occurs with other
Homer family members.
Other PSD proteins reportedly regulated by UPS include Shank [22],
GKAP [22,23,48], and AKAP79/109 [22]. The ubiquitination and the
subsequent levels of Shank, GKAP, and AKAP79/109 were shown to all
be regulated in a similar fashion by neuronal activity [22]. Treatment
of cortical neuronal cultures with tetrodotoxin (TTX), an inhibitor
of neuronal action potential ﬁring, reduced the ubiquitination and
increased the levels of all three proteins; whereas, treatment of the
cultures with bicuculline, an antagonist of γ-aminobutyric acid
(GABA) receptor A, GABA(A) receptor, resulted in the reverse effect.
However, thesemanipulations of neuronal activity produced completely
opposite effects on other scaffold proteins, such as PSD-95 and Homers
[22,36,45]. This differential regulation suggests that the activity-
induced ubiquitination of scaffold proteins might occur differently in
different regions within the PSD, such as the region closer to the
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plasm where Shank is concentrated [49]. This scenario will suggest an
activity-dependent rearrangement of PSD structures within the same
synapse. A real-time, imaging-based experiment to determine the
level of these scaffold proteins in synapses during activity manipulation
might give us an insight into how scaffold proteins are differentially
regulated.
4. Ubiquitination of neurotransmitter receptors
Neurotransmitter receptors at the postsynaptic cells are the main
players in regulating synaptic transmission. Multiple receptors have
been identiﬁed in an unbiased screening for ubiquitinated proteins
[23]. Among them, glutamate receptors are of particular interest
due to their importance for synapse plasticity and their role in
neurodevelopmental and psychiatric disorders. Consequently, the regu-
lation of glutamate receptors by ubiquitination has become a focus of
study.
One of themostwell-known glutamate-gated receptors is the AMPA
receptor, which mediates fast synaptic transmission. The insertion and
removal of AMPA receptor subunits are two of the major mechanisms
involved in synaptic strength and are considered the most well-
studied mechanism in long-term synapse plasticity [50,51]. A study to
determine if ubiquitination can mediate the functions of the AMPA
receptor showed that theAMPA receptor subunit GluA1 is ubiquitinated
during AMPA-triggered neuronal activity [52]. The same study also
demonstrated that this ubiquitination most likely occurs at the lysine-
rich region of the GluA1 C-terminus and involves the E3 ligase
known as the neural-precursor cell-expressed developmentally down-
regulated gene 4-1 (Nedd4-1). Most importantly, this particular
ubiquitination event regulates the endocytic properties of GluA1-
containing AMPA receptors rather than leading to direct protein degra-
dation. A subsequent study revealed that promoting neuronal activity,
by using either the GABA-A receptor antagonist or AMPA receptor
agonist, induces ubiquitination of theGluA2 subunit of the AMPA recep-
tor and subsequently leads to receptor endocytosis [53]. Although
multiple studies have demonstrated ubiquitin-mediated regulation of
membrane proteins in neuronal cells [54–56], the AMPA receptor is
the ﬁrst postsynaptic receptor whose endocytosis has been shown to
be regulated by ubiquitination.
Another critical glutamate-gated ion channel is the NMDA receptor.
Upon activation, NMDA receptor is permeable by several ions, including
calcium. The inﬂux of calcium into postsynaptic cells initiates a number
of signaling cascades that are important for synapse plasticity and
memory-related processes. Therefore, much effort has been applied to
understanding the regulation of NMDA receptor functions, including
posttranslational modiﬁcations. Several different regulatory mecha-
nisms have been identiﬁed thus far. It was recently reported that
the NR2B subunit of the NMDA receptor can be ubiquitinated by the
E3 ligase Mind bomb-2 (Mib2) [57]. Although it is unclear if the
ubiquitination of NR2B leads to receptor endocytosis, degradation, or
other downstream signaling cascades, the same study demonstrated
the possibility that ubiquitination can regulate the function of the
NMDA receptor.
In addition to the ionotropic glutamate receptors, such as the AMPA
and NMDA receptors, the metabotropic glutamate receptors (mGluRs)
are also critical for synapse plasticity, especially in the case of long-
term depression (LTD). Among the members of two groups of mGluRs,
group 1 and 2, two members of group 1 have been reported to
be ubiquitinated. A study found that the ubiquitin E3 ligase Seven in
absentia homolog 1A (Siah1a) can ubiquitinate both mGluR1a and
mGluR5, which leads to their proteasome degradation [58]. A follow-
up study indicated that such ubiquitination, especially of mGluR1a,
requires the long isomer Homer3 as a shuttling protein to bring
ubiquitinated mGluR1a to the proteasomes through interaction with
the proteasome component S8 ATPase [40]. Because mGluRs are bothtriggering and being activated by various signaling cascades, it would
be of particular interest to understand 1) under what circumstances
mGluRs are ubiquitinated and 2) what the consequences of the
ubiquitination of mGluRs are.
Another postsynaptic receptor known to be ubiquitinated is the
GABA(A) receptor. GABA(A) receptor is the major ligand-gated ion
channel that mediates fast synaptic inhibition. A study has shown that
chronic inhibition of neuronal activity increases the level of the
GABA(A) receptor ubiquitination and reduces its cell surface stability,
while increasing neuronal activity results in reverse effects [59]. Along
with the same logic, the trafﬁcking of GABA(A) receptor subunit into
lysosome for degradation is also regulated by ubiquitination [60]. This
regulation occurs particularly in the intracellular domain of the γ2
subunit. In summary, these data provide another mechanism to regu-
late synapse plasticity through ubiquitination on neurotransmitter
receptors.
5. Ubiquitination of other signaling molecules
Synapse plasticity is regulated by various signaling pathways
especially in neuronal activity events. Amongmany signalingmolecules
regulated by UPS, three proteins are currently attractingmuch attention
due to their importance at the postsynaptic terminals. The ﬁrst is the
activity-regulated cytoskeleton-associated protein (Arc) [61]. It is well
known that Arc facilitates the internalization of AMPA receptors
[62,63]. Because of this, the level of Arc has been directly implicated in
many synapse-weakening processes, including in synaptic long-term
depression (LTD) [62,63] and synapse elimination [64]. Ube3A was the
ﬁrst ubiquitin E3 ligase identiﬁed for Arc. Back in the late 1990s, studies
showed that the loss of a maternal copy of the UBE3A gene accounts for
over 80% of Angelman Syndrome cases, a severe neurodevelopmental
disorder [65,66]. During the past 5 years, multiple studies proposed
that dysregulation of the AMPA receptor level in synapses triggered by
abnormal Arc ubiquitination might lead to the symptoms seen in
Angelman Syndrome [67,68]. However, recent studies questioned if
Ube3A is themost critical E3 ligase for Arc [69,70]. The second ubiquitin
E3 ligase identiﬁed for Arc is the RING domain ubiquitin ligase Triad3A
[69]. In Triad3A-knockdown cells, Arc is accumulated, and the level of
the surface AMPA receptor is reduced accordingly. Because of the role
of Arc in activity-dependent synapse plasticity, Triad3A, therefore,
appears to act as a terminator for Arc-mediated events during neuronal
activity.
Another signaling protein ubiquitinated at the postsynaptic
terminal is Ca2+/calmodulin-dependent protein kinase II (CaMKII)
[23]. CaMKII regulates synapse plasticity at postsynaptic terminals
through various mechanisms, including phosphorylating the subunits
of AMPA and NMDA receptors [71,72], acting as a scaffold component
at PSD [73,74], and regulating proteasome movement into dendritic
spines [2,75] (discussed later). Although both the identity of the E3
ligase speciﬁc for CaMKII and the consequences of the ubiquitination
of CaMKII are still unclear, exploring the effects of CaMKII ubiquitination
in synapse plasticity is an important research direction, especially given
the diverse roles played by CaMKII at the synapses.
The ﬁnal postsynaptic signaling molecule being ubiquitinated is the
spine-associated Rap guanosine triphosphatase activating protein
(SPAR) [76]. SPAR is an actin regulatory protein that is critical for
controlling dendritic spine morphology. Upon neuronal activity stimu-
lation, SPAR is phosphorylated by polo-like kinase 2 (Plk2) [77,78],
which leads to SPAR ubiquitination and degradation, and subsequent
synapse weakening [76,78]. The β-Transducin Repeat Containing
Protein Ligase (β-TRCP), one of the four subunits in Skp1/Cul1/F-box
protein (SCF) complex, is identiﬁed as the E3 ligase responsible for
SPAR ubiquitination. Because of the indispensable functions of SPAR in
regulating dendritic spine morphology, the ubiquitination of SPAR
has important implications for affecting synapse plasticity, such as
homeostatic synapse plasticity [77–79].
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Proteasomes are involved in both synapse formation [13,80] and
synapse elimination [81] induced by neuronal activity. Consequently, in
addition to the modulation of synaptic function through ubiquitination
and degradation of speciﬁc proteins, coordination of proteasome activ-
ity in neurons and synapses is another form of regulation. For example,
studies show that the levels of multiple proteasome subunits and
regulatory genes are controlled by and associatedwithneuronal plastic-
ity through speciﬁc transcription factors, such as Zif268 [82], as well as
through signaling molecules and events, such as CaMKII [83] and
phosphorylation of Rpt6 [84]. Another form of regulation controls the
accessibility of the proteasomes to ubiquitinated proteins in the
synapses. A study has shown that in neuronal synapses the proteasome
is able tomove fromdendritic shafts into dendritic spines during neuro-
nal activity [85]. This was observed by tracking the movement of
GFP-tagged proteasome component Rpt1 [85]. Later, it was shown
that this sequestration and the subsequent activation of the proteasome
require auto-phosphorylation of CaMKIIalpha at Ser-286 and phosphor-
ylation of Rpt6 at Ser-120 by CaMKII [75]. These studies suggest that the
activation of the proteasomes in synapses might promote widespread
destruction in synapses in some neuronal conditions such as long-
term depression (LTD) [86–88].
7. Conclusions
UPS plays an extremely important role in the control of cellular
homeostasis. In addition to the simple degradation of ubiquitinated pro-
teins, multiple layers of regulation by UPS through various modulations
provide temporal and spatial control of speciﬁc proteins. In neuronal
cells, the structure and function of individual synapses are usually
different and hence require ﬁne-tuned, individual regulation. UPS
provides away tomodify synapses by controlling thequantity of speciﬁc
proteins. The speciﬁcity of this regulation is provided by the hundreds of
E3 ligases and their speciﬁc substrates. However, current literature in
the ﬁeld is still in need of a systematic approach to the identiﬁcation
and analysis of the network of E3 ligases and protein ubiquitination in
the central nervous system. Future efforts in such a direction will lead
to a broader understanding of protein ubiquitination in the central
nervous system and, hopefully, to facilitation of our understanding of
the regulation of synapse plasticity.
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